The Patent Finder

Glaxo Wellcome House

Also on record
Records under this name other than patents Glaxo Wellcome House holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Showing 1 to 4 of 4 · Back to Glaxo Wellcome House

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 5,552,404Opioid compounds and methods for using same
Formerly held
Term ended
Term ended no later than Sep 3, 2016 · Low confidence
Term endedTerm ended no later than Sep 3, 2016Low confidence
US 5,574,159Opioid compounds and methods for making therefor
Formerly held
Term ended
Term ended no later than Nov 12, 2016 · Low confidence
Term endedTerm ended no later than Nov 12, 2016Low confidence
US 5,658,908Opioid diarylmethylpiperazines and piperdines
Formerly held
Term ended
Term ended no later than Aug 19, 2017 · Low confidence
Term endedTerm ended no later than Aug 19, 2017Low confidence
US 5,681,830Opioid compounds
Formerly held
Term ended
Term ended no later than Oct 28, 2017 · Low confidence
Term endedTerm ended no later than Oct 28, 2017Low confidence
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 22, 2026 · includes USPTO assignment data published Nov 21, 2026, status data published Nov 22, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited